Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Milena Colovic"'
Autor:
Gianfranco Caselli, Albino Bonazzi, Marco Lanza, Flora Ferrari, Daniele Maggioni, Cristian Ferioli, Roberto Giambelli, Eleonora Comi, Silvia Zerbi, Marco Perrella, Ornella Letari, Elena Di Luccio, Milena Colovic, Stefano Persiani, Tiziano Zanelli, Laura Mennuni, Tiziana Piepoli, Lucio Claudio Rovati
Publikováno v:
Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-19 (2018)
Abstract Background Prostaglandin E2 (PGE2) acts via its EP4 receptor as a cytokine amplifier (e.g., interleukin [IL]-6) and induces the differentiation and expansion of inflammatory T-helper (Th) lymphocytes. These mechanisms play a key role in the
Externí odkaz:
https://doaj.org/article/22fc8ca4e2234150b60717587ab81196
Autor:
Milena Colovic, Hua Yang, Lily Southcott, Helen Merkens, Nadine Colpo, Francois Bénard, Paul Schaffer
Publikováno v:
Journal of Nuclear Medicine. :jnumed.122.265254
Autor:
M Montagna, Tiziana Piepoli, O Letari, R Artusi, Milena Colovic, G Caselli, L C Rovati, Chiara Galimberti, S Persiani
Publikováno v:
Neuro Oncol
BACKGROUND Glioblastoma multiforme (GBM) is the most malignant primary brain cancer. Several mutations and alterations of key cellular pathways including tyrosine kinases (TKs) are involved in GBM etiopathogenesis. Currently there is no cure for GBM.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de4834f76d275d0d2d6d8d5f4af168cb
https://europepmc.org/articles/PMC6796123/
https://europepmc.org/articles/PMC6796123/
Autor:
Tiziana Piepoli, Chiara Galimberti, Silvia Zerbi, Gianfranco Caselli, Roberto Artusi, Ornella Letari, Giuseppe M. Montagna, Milena Colovic, Stefano Persiani, Lucio C. Rovati
Publikováno v:
Cancer Research. 80:4219-4219
BACKGROUND: Currently there is no cure for glioblastoma (GBM), the most malignant primary brain cancer. Glioblastoma etiopathogenesis involves mutations and alterations of key signaling pathways including tyrosine kinases (TKs). Notably, aberrant act
Autor:
Lucio C. Rovati, C. Benvenuti, Monique Zangarini, G. Giacovelli, Federica Sala, Stefano Persiani, Milena Colovic, Beatrice Barbetta, C. Manzotti, Cristina Vitalini, Y. Donazzolo
Publikováno v:
Drug Research. 66:136-140
Background: Post-menopausal women under treatment with levothyroxine for their medical conditions may take concomitantly dietary supplements containing soy isoflavones in combination to treat their post-menopausal symptoms. The aim of this study was
Publikováno v:
Journal of Chromatography B. :1-9
To investigate the pharmacokinetics of silibinin and silibinin hemisuccinate in human plasma, two high-performance liquid chromatography–tandem mass spectrometry (HPLC–MS/MS) methods were developed and validated. The methods require a small volum
Autor:
Gabriella Spaltro, Herbert Schneider, Caterina Bendotti, Milena Colovic, Claudia Fracasso, Massimo Tortarolo, Giuliano Grignaschi, Novella Calvaresi, Silvio Caccia, Giovanna Guiso, Bernd Elger, Bernd Seilheimer, Eleonora Zennaro
Publikováno v:
Journal of Neuroscience Research. 83:134-146
Amyotrophic lateral sclerosis (ALS) is a fatal neurological disorder involving the selective degeneration of motor neurons. In a small proportion of patients, ALS is caused by mutations in copper/zinc superoxide dismutase (SOD1), and mice overexpress
Autor:
null Stefano Persiani, null Federica Sala, null Monique Zangarini, null Carla Manzotti, null Milena Colovic, null Yves Donazzolo, null Beatrice Barbetta, null Cristina Vitalini, null Giampaolo Giacovelli, null Claudio Benvenuti, null Lucio C. Rovati
Publikováno v:
Journal of Pharmacy and Pharmacology. 2
Autor:
null Stefano Persiani, null Federica Sala, null Carla Manzotti, null Milena Colovic, null Yves Donazzolo, null Beatrice Barbetta, null Cristina Vitalini, null Giampaolo Giacovelli, null Claudio Benvenuti, null Lucio C. Rovati
Publikováno v:
Journal of Pharmacy and Pharmacology. 2
Autor:
Ilaria Ceglia, Roberto W. Invernizzi, Claudia Fracasso, Milena Colovic, Silvio Caccia, Sabrina Acconcia
Publikováno v:
British Journal of Pharmacology. 142:469-478
Microdialysis was used to study the acute and chronic effects of escitalopram (S-citalopram; ESCIT) and chronic citalopram (CIT), together with the 5-HT1A receptor antagonist WAY100,635 (N-[2-[methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl) cyclo